Stereotaxis to Present at the Seventh Annual JMP Securities Research Conference

Attendance at the conference is by invitation only. The audio presentation will be webcast live and remain available for 90 days at http://www.wsw.com/webcast/jmp6/stxs/.

About Stereotaxis

Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Stereotaxis System is designed to enable physicians to complete more complex interventional procedures by providing image guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using computer-controlled, externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, shorter procedure time and reduced x-ray exposure. The core components of the Stereotaxis system have received regulatory clearance in the U.S.,Europe andCanada.

     Company Contact:
     Jim Stolze
     Chief Financial Officer
     314-678-6105

     Investor Contact:
     EVC Group, Inc.
     Doug Sherk & Jenifer Kirtland
     415-896-6820

     Media Contact:
     EVC Group, Inc.
     Steve DiMattia
     646-201-5445

SOURCE Stereotaxis, Inc.

Copyright © 2008, PRNewswire
Copyright © 2008, NewsBlaze, Daily News

Tags: Healthcare, Pharmaceuticals, Biotechnology, Banking and Finance, Health, missouri, california

   _   _

         

Is your favorite bookmark site missing? Ask for it.